Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • United Therapeutics pays $140M for thymic cell therapy startup

United Therapeutics pays $140M for thymic cell therapy startup

July 3, 2026Posted inBiotechnology

United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell therapies focused on the thymus.

Post navigation

Previous Post
AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC

Recent Posts

  • United Therapeutics pays $140M for thymic cell therapy startup
  • AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC
  • Synthetic Organizers Aid Creation of Reproducible Kidney Organoids from Stem Cells
  • Elixirgen Builds Rare Disease Pipeline Around Telomere Biology Disorders and DMD
  • Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top